Early research (Phase 1)Study completedNCT04006704
What this trial is testing
Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo Tablets
Who this might be right for
HIV-1
Janssen Pharmaceutica N.V., Belgium 25